Santarus Reports Third Quarter 2011 Financial Results
Santarus, Inc . , a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended September 30, 2011.Full Story
Central District, Hong Kong
#1 Dec 1, 2011
These article is very helpful to me.. Its great.
Add your comments below
|The murine appendiceal microbiome is altered in...||Jul '14||Terry||1|
|New treatment could help those with Crohn's, co... (Oct '13)||Jun '14||question||12|
|Study Finds No Tie Between Acne Drug Accutane a... (Mar '13)||Jan '14||Zonnya||10|
|FDA Approves Uceris (Budesonide) for Patients W... (Jan '13)||Oct '13||Chuck||2|
|Tax benefit, higher sales lift Santarus 2Q prof... (Aug '13)||Aug '13||Brett Steele||1|
|Clinical and radiological characteristics of lu... (Aug '13)||Aug '13||Carmen||1|
|New Market Report Now Available: InDex Pharmace... (Jun '13)||Jun '13||mr ade||2|
Find what you want!
Search Ulcerative Colitis Forum Now
Copyright © 2014 Topix LLC